InvestorsHub Logo
Followers 7
Posts 444
Boards Moderated 0
Alias Born 01/22/2006

Re: None

Wednesday, 02/13/2013 1:31:28 PM

Wednesday, February 13, 2013 1:31:28 PM

Post# of 346232
I have never held PPHM management in high regard. They've almost become an afterthought at this point in my assessments of this company and BAVI. They have never considered retail anything more than an entity that must be tolerated until they get BP on board.

I agree with investors here much smarter than me that the apparent results tell us less than what meets the eye. Most of these pancreatic cancer patients were very sick to begin with and had already shown resistance to any further treatment (and among many the disease had progressed into the liver which I understand is what eventually causes patient death). They simply may not have had time for the immuno aspects of BAVI to develop. So, as per usual with PPHM, we are left with more questions than answers. This management does weary me.

All this being said, I expect a better buying opportunity when the gap at $1.65 is closed. I attach a monthly chart which illustrates two indicators that have consistently corrected at near these levels. The entire market is due for a correction and I don't think PPHM will be exempt when it occurs. All IMO -- and I stand willing to be corrected by those who are far more veteran at this game than me.

http://tinyurl.com/cqbndw6

P.S. I would like to hear from informed posters Cloaked Protector and RRdog about their take after reflecting on today's PR.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News